Prelude Capital Management’s CVS Health CVS Stock Holding History

Prelude Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,500	Closed	-$1.08M	–	1905
2021 Q4	$1.08M	Buy	10,500 +100	+1%	+$9.24K	0.03%	565
2021 Q3	$883K	Hold	10,400	–	–	0.02%	616
2021 Q2	$868K	Sell	10,400 -39,600	-79%	-$3.24M	0.03%	690
2021 Q1	$3.76M	Sell	50,000 -20,600	-29%	-$1.5M	0.1%	147
2020 Q4	$4.82M	Buy	+70,600	New	+$4.59M	0.12%	111
2020 Q3	–	Sell	-40,300	Closed	-$2.62M	–	1918
2020 Q2	$2.62M	Hold	40,300	–	–	0.14%	119
2020 Q1	$2.39M	Buy	40,300 +300	+0.8%	+$20K	0.16%	85
2019 Q4	$2.97M	Hold	40,000	–	–	0.11%	119
2019 Q3	$2.52M	Hold	40,000	–	–	0.11%	141
2019 Q2	$2.18M	Sell	40,000 -5,800	-13%	-$312K	0.11%	176
2019 Q1	$2.47M	Buy	+45,800	New	+$2.83M	0.14%	142
2017 Q4	–	Sell	-17,900	Closed	-$1.46M	–	1419
2017 Q3	$1.46M	Buy	+17,900	New	+$1.42M	0.13%	167

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Prelude Capital Management's CVS Position: Q2 2026 in Review

Prelude Capital Management reduced its CVS Health (CVS) stake by 22% in Q2 2026, selling an estimated $223K and leaving 9,023 shares worth $933K. The position accounts for 0.07% of the portfolio, ranked #329.

Prelude Capital Management first reported a position in CVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $4.1M in Q1 2022. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Prelude Capital Management held 9,023 shares of CVS Health worth $933K as of Q2 2026.
Prelude Capital Management sold 2,495 CVS Health shares in Q2 2026, an estimated $223K.
CVS Health made up 0.07% of Prelude Capital Management's portfolio in Q2 2026, its #329 holding.
Prelude Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 36 quarters since.
Prelude Capital Management's CVS Health position peaked at $4.1M in Q1 2022.
2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.